128 related articles for article (PubMed ID: 90788)
1. Interferon therapy in myelomatosis.
Mellstedt H; Aahre A; Bjørkholm M; Cantell K; Holm G; Johansson B; Strander H
Lancet; 1979 Sep; 2(8144):697. PubMed ID: 90788
[No Abstract] [Full Text] [Related]
2. The therapy of multiple myeloma with the interferons.
Bonnem EM
Cancer Treat Rev; 1988 Jan; 15 Suppl A():35-41. PubMed ID: 2449280
[No Abstract] [Full Text] [Related]
3. Interferon therapy in myelomatosis.
Smith H
Lancet; 1979 Jun; 1(8128):1248-9. PubMed ID: 87719
[No Abstract] [Full Text] [Related]
4. Interferon therapy in myelomatosis.
Rosenfelt F
Lancet; 1979 Mar; 1(8117):674. PubMed ID: 85915
[No Abstract] [Full Text] [Related]
5. [Treatment of multiple myeloma with interferon].
Bruno S
Medicina (B Aires); 1996; 56 Suppl 1():92-4. PubMed ID: 9224981
[No Abstract] [Full Text] [Related]
6. [Interferon: a new weapon in the therapeutic strategy of multiple myeloma].
Avvisati G; Petrucci MT; Mandelli F
Haematologica; 1990; 75 Suppl 4():68-71. PubMed ID: 1705913
[No Abstract] [Full Text] [Related]
7. Interferon therapy in multiple myeloma: failure of human fibroblast interferon administration to the course of light chain disease.
Billiau A; Bloemmen J; Bogaerts M; Claeys H; Van Damme J; De Ley M; de Somer P; Drochmans A; Heremans H; Kriel A; Schetz J; Tricot G; Vermylen C; Verwilghen R; Waer M
Eur J Cancer Clin Oncol; 1981 Aug; 17(8):875-82. PubMed ID: 6173221
[No Abstract] [Full Text] [Related]
8. [Interferon (IFN) in multiple myeloma and non-Hodgkin's lymphoma].
Gola A
Acta Haematol Pol; 1994; 25(2 Suppl 1):136-41. PubMed ID: 7520658
[TBL] [Abstract][Full Text] [Related]
9. Interferon therapy in myelomatosis.
Mellstedt H; Ahre A; Björkholm M; Holm G; Johansson B; Strander H
Lancet; 1979 Feb; 1(8110):245-7. PubMed ID: 84901
[TBL] [Abstract][Full Text] [Related]
10. Prolonged survival in resistant myeloma after treatment with interferon--a case report and review.
Edwards DR
Hematol Oncol; 1991; 9(1):1-7. PubMed ID: 1710594
[No Abstract] [Full Text] [Related]
11. Interferon in the treatment of multiple myeloma and the non-Hodgkin's lymphomas.
Wagstaff J; Scarffe JH; Crowther D
Cancer Treat Rev; 1985 Dec; 12 Suppl B():39-44. PubMed ID: 2421896
[No Abstract] [Full Text] [Related]
12. [Role of interferon in the treatment of multiple myeloma].
Shimazaki C
Nihon Rinsho; 2006 Jul; 64(7):1291-6. PubMed ID: 16838647
[TBL] [Abstract][Full Text] [Related]
13. Interferons for the treatment of hematological malignancies.
Urabe A
Oncology; 1994; 51(2):137-41. PubMed ID: 7515169
[TBL] [Abstract][Full Text] [Related]
14. Usages of interferon and interferon inducers in man: the second half of 1980.
Pollard RB
Med Biol; 1981 Apr; 59(2):69-76. PubMed ID: 6171689
[No Abstract] [Full Text] [Related]
15. Interferon: a new name in cancer treatment.
Lancaster J
Nurs RSA; 1987 Feb; 2(2):28-9. PubMed ID: 2438555
[No Abstract] [Full Text] [Related]
16. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
17. [Antineoplastic effects of interferons].
Shimoyama M
Nihon Rinsho; 1986 Feb; 44(2):395-402. PubMed ID: 2422409
[No Abstract] [Full Text] [Related]
18. Management of multiple myeloma.
Richards JD; Singer CR; Tobias JS
Br J Hosp Med; 1987 May; 37(5):437, 440-2. PubMed ID: 2437986
[TBL] [Abstract][Full Text] [Related]
19. Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma.
Barlogie B; Alexanian R
Cancer Res; 1989 Dec; 49(24 Pt 1):7172-5. PubMed ID: 2479477
[No Abstract] [Full Text] [Related]
20. When interference can be good.
Higginson J
Nurs Mirror; 1984 Jan; 158(2):36-8. PubMed ID: 6198639
[No Abstract] [Full Text] [Related]
[Next] [New Search]